Literature DB >> 31619553

HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.

Philip R Tedbury1, Mariia Novikova1, Ayna Alfadhli2, Yuta Hikichi1, Ioannis Kagiampakis3, Vineet N KewalRamani3, Eric Barklis2, Eric O Freed4.   

Abstract

The matrix (MA) domain of HIV-1 Gag plays key roles in virus assembly by targeting the Gag precursor to the plasma membrane and directing the incorporation of the viral envelope (Env) glycoprotein into virions. The latter function appears to be in part dependent on trimerization of the MA domain of Gag during assembly, as disruption of the MA trimer interface impairs Env incorporation. Conversely, many MA mutations that impair Env incorporation can be rescued by compensatory mutations in the trimer interface. In this study, we sought to investigate further the biological significance of MA trimerization by isolating and characterizing compensatory mutations that rescue MA trimer interface mutants with severely impaired Env incorporation. By serially propagating MA trimerization-defective mutants in T cell lines, we identified a number of changes in MA, both within and distant from the trimer interface. The compensatory mutations located within or near the trimer interface restored Env incorporation and particle infectivity and permitted replication in culture. The structure of the MA lattice was interrogated by measuring the cleavage of the murine leukemia virus (MLV) transmembrane Env protein by the viral protease in MLV Env-pseudotyped HIV-1 particles bearing the MA mutations and by performing crystallographic studies of in vitro-assembled MA lattices. These results demonstrate that rescue is associated with structural alterations in MA organization and rescue of MA domain trimer formation. Our data highlight the significance of the trimer interface of the MA domain of Gag as a critical site of protein-protein interaction during HIV-1 assembly and establish the functional importance of trimeric MA for Env incorporation.IMPORTANCE The immature Gag lattice is a critical structural feature of assembling HIV-1 particles, which is primarily important for virion formation and release. While Gag forms a hexameric lattice, driven primarily by the capsid domain, the MA domain additionally trimerizes where three Gag hexamers meet. MA mutants that are defective for trimerization are deficient for Env incorporation and replication, suggesting a requirement for trimerization of the MA domain of Gag in Env incorporation. This study used a gain-of-function, forced viral evolution approach to rescue HIV-1 mutants that are defective for MA trimerization. Compensatory mutations that rescue virus replication do so by restoring Env incorporation and MA trimer formation. This study supports the importance of MA domain trimerization in HIV-1 replication and the potential of the trimer interface as a therapeutic target.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Gag; assembly; envelope; human immunodeficiency virus; retrovirus

Mesh:

Substances:

Year:  2019        PMID: 31619553      PMCID: PMC6912099          DOI: 10.1128/JVI.01526-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Automated analysis of interatomic contacts in proteins.

Authors:  V Sobolev; A Sorokine; J Prilusky; E E Abola; M Edelman
Journal:  Bioinformatics       Date:  1999-04       Impact factor: 6.937

Review 2.  HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.

Authors:  Mary Ann Checkley; Benjamin G Luttge; Eric O Freed
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

3.  A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles.

Authors:  Laura Brandano; Mario Stevenson
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

4.  A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein.

Authors:  B A Brody; S S Rhee; M A Sommerfelt; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

5.  Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.

Authors:  T Murakami; E O Freed
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles.

Authors:  D J Wyma; A Kotov; C Aiken
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment.

Authors:  Anjali Joshi; Sherimay D Ablan; Ferri Soheilian; Kunio Nagashima; Eric O Freed
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

9.  Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.

Authors:  E O Freed; M A Martin
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex.

Authors:  Mingli Qi; Janice A Williams; Hin Chu; Xuemin Chen; Jaang-Jiun Wang; Lingmei Ding; Ehiole Akhirome; Xiaoyun Wen; Lynne A Lapierre; James R Goldenring; Paul Spearman
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

View more
  14 in total

1.  Structural and Mechanistic Studies of the Rare Myristoylation Signal of the Feline Immunodeficiency Virus.

Authors:  Janae B Brown; Holly R Summers; Lola A Brown; Jan Marchant; Paige N Canova; Colin T O'Hern; Sophia T Abbott; Constance Nyaunu; Simon Maxwell; Talayah Johnson; Morgan B Moser; Sherimay D Ablan; Hannah Carter; Eric O Freed; Michael F Summers
Journal:  J Mol Biol       Date:  2020-05-19       Impact factor: 5.469

2.  Atomic view of the HIV-1 matrix lattice; implications on virus assembly and envelope incorporation.

Authors:  Alexandra B Samal; Todd J Green; Jamil S Saad
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-03       Impact factor: 12.779

3.  Elucidating the Basis for Permissivity of the MT-4 T-Cell Line to Replication of an HIV-1 Mutant Lacking the gp41 Cytoplasmic Tail.

Authors:  Melissa V Fernandez; Huxley K Hoffman; Nairi Pezeshkian; Philip R Tedbury; Schuyler B van Engelenburg; Eric O Freed
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

4.  Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.

Authors:  Shijian Zhang; Hanh T Nguyen; Haitao Ding; Jia Wang; Shitao Zou; Lihong Liu; Debjani Guha; Dana Gabuzda; David D Ho; John C Kappes; Joseph Sodroski
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

5.  HIV-1 matrix-tRNA complex structure reveals basis for host control of Gag localization.

Authors:  Charles Bou-Nader; Frauke Muecksch; Janae B Brown; Jackson M Gordon; Ashley York; Chen Peng; Rodolfo Ghirlando; Michael F Summers; Paul D Bieniasz; Jinwei Zhang
Journal:  Cell Host Microbe       Date:  2021-08-11       Impact factor: 31.316

Review 6.  Recent Advances in HIV-1 Gag Inhibitor Design and Development.

Authors:  Alexej Dick; Simon Cocklin
Journal:  Molecules       Date:  2020-04-07       Impact factor: 4.411

Review 7.  The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.

Authors:  R Elliot Murphy; Jamil S Saad
Journal:  Viruses       Date:  2020-05-16       Impact factor: 5.048

Review 8.  Revisiting Membrane Microdomains and Phase Separation: A Viral Perspective.

Authors:  Prabuddha Sengupta; Jennifer Lippincott-Schwartz
Journal:  Viruses       Date:  2020-07-10       Impact factor: 5.048

9.  In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix.

Authors:  Nicaise Ndembi; Ravindra K Gupta; Rawlings Datir; Steven Kemp; Kate El Bouzidi; Petra Mlchocova; Richard Goldstein; Judy Breuer; Greg J Towers; Clare Jolly; Miguel E Quiñones-Mateu; Patrick S Dakum
Journal:  mBio       Date:  2020-11-03       Impact factor: 7.867

10.  Maturation of the matrix and viral membrane of HIV-1.

Authors:  Zunlong Ke; Vojtech Zila; Kun Qu; Maria Anders-Össwein; Bärbel Glass; Frauke Mücksch; Rainer Müller; Carsten Schultz; Barbara Müller; Hans-Georg Kräusslich; John A G Briggs
Journal:  Science       Date:  2021-08-06       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.